Suchergebnisse - "JAK inhibitor"

PubPharm (423)

1

Systemic Treatment of Psoriasis with JAK Inhibitors: A Review

enthalten in: Dermatology and therapy | 2019

von Kvist-Hansen, A. | Hansen, P. | Skov, L.

2

An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature

enthalten in: Clinical case reports | 2019

von Berbert Ferreira, R. | Ferreira, S. | Scheinberg, M.

3

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis : A Phase IIb, Open-Label Extension Study

enthalten in: Rheumatology and therapy | 2019

von Genovese, M. | Greenwald, M. | Gutierrez-Ureña, S. | +11

4

Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib

enthalten in: JAAD case reports | 2019

von Damsky, W. | Vesely, M. | Lee, A. | +5

5

New and Emerging Topical Therapies for Psoriasis and Atopic Dermatitis

enthalten in: The Journal of clinical and aesthetic dermatology | 2019

von Psomadakis, C. | Han, G.

6

Outcomes of dose reduction, withdrawal, and restart of tofacitinib in patients with rheumatoid arthritis : a prospective observational study

enthalten in: Clinical rheumatology | 2019

von Mori, S. | Ueki, Y.

7

Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs : results from SELECT-NEXT

enthalten in: Arthritis research & therapy | 2019

von Strand, V. | Pope, J. | Tundia, N. | +7

ErratumIn: Arthritis Res Ther. 2020 Jun 9;22(1):137. - PMID 32517782

8

Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

enthalten in: Arthritis Research & Therapy | 2019

von Strand, V. | Pope, J. | Tundia, N. | +7

9

Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

enthalten in: Arthritis Research & Therapy | 2019

von Strand, V. | Pope, J. | Tundia, N. | +7

10

Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review

enthalten in: Rheumatology international | 2019

von Karadeniz, H. | Güler, A. | Atas, N. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]